Mochida Pharmaceutical Co., Ltd. (JP:4534)
:4534
Want to see JP:4534 full AI Analyst Report?
Total Valuation
Mochida Pharmaceutical Co., Ltd. has a market cap or net worth of ¥124.37B. The enterprise value is ¥111.50B.
Market Cap¥124.37B
Enterprise Value¥111.50B
Share Statistics
Mochida Pharmaceutical Co., Ltd. has 36,390,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding36,390,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Mochida Pharmaceutical Co., Ltd.’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 4.63%.
Return on Equity (ROE)0.06
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)4.63%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee76.84M
Profits Per Employee5.19M
Employee Count1,522
Asset Turnover0.64
Inventory Turnover1.68
Valuation Ratios
The current PE Ratio of Mochida Pharmaceutical Co., Ltd. is 19.6. Mochida Pharmaceutical Co., Ltd.’s PEG ratio is 0.40.
PE Ratio19.6
PS Ratio1.05
PB Ratio0.87
Price to Fair Value0.87
Price to FCF-12.21
Price to Operating Cash Flow0.00
PEG Ratio0.40
Income Statement
In the last 12 months, Mochida Pharmaceutical Co., Ltd. had revenue of 116.95B and earned 7.90B in profits. Earnings per share was 222.93.
Revenue116.95B
Gross Profit56.26B
Operating Income10.15B
Pretax Income11.17B
Net Income7.90B
EBITDA13.13B
Earnings Per Share (EPS)222.93
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Mochida Pharmaceutical Co., Ltd. pays an annual dividend of ¥40, resulting in a dividend yield of 2.34%
Dividend Per Share¥40
Dividend Yield2.34%
Payout Ratio42.23%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.66
52-Week Price Change22.35%
50-Day Moving Average3.51K
200-Day Moving Average3.36K
Relative Strength Index (RSI)63.82
Average Volume (3m)34.37K
Important Dates
Mochida Pharmaceutical Co., Ltd. upcoming earnings date is Jul 31, 2026, TBA (Not Confirmed).
Last Earnings DateMay 15, 2026
Next Earnings DateJul 31, 2026
Ex-Dividend Date―
Financial Position
Mochida Pharmaceutical Co., Ltd. as a current ratio of 4.29, with Debt / Equity ratio of 7.13%
Current Ratio4.29
Quick Ratio2.99
Debt to Market Cap0.08
Net Debt to EBITDA-1.38
Interest Coverage Ratio140.94
Taxes
In the past 12 months, Mochida Pharmaceutical Co., Ltd. has paid 3.27B in taxes.
Income Tax3.27B
Effective Tax Rate0.29
Enterprise Valuation
Mochida Pharmaceutical Co., Ltd. EV to EBITDA ratio is 7.97, with an EV/FCF ratio of -10.41.
EV to Sales0.89
EV to EBITDA7.97
EV to Free Cash Flow-10.41
EV to Operating Cash Flow-14.23
Balance Sheet
Mochida Pharmaceutical Co., Ltd. has ¥54.69B in cash and marketable securities with ¥830.00M in debt, giving a net cash position of ¥53.86B billion.
Cash & Marketable Securities¥54.69B
Total Debt¥830.00M
Net Cash¥53.86B
Net Cash Per Share¥1.48K
Tangible Book Value Per Share¥3.96K
Margins
Gross margin is 48.11%, with operating margin of 8.68%, and net profit margin of 6.76%.
Gross Margin48.11%
Operating Margin8.68%
Pretax Margin9.55%
Net Profit Margin6.76%
EBITDA Margin11.22%
EBIT Margin8.68%
Analyst Forecast
The average price target for Mochida Pharmaceutical Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast11.21%
EPS Growth Forecast39.02%